(BMT CTN Protocol 0901) A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia
Description: 

The study is designed as a Phase III, multicenter trial comparing outcomes after allogenetic hematopoietic stem cell transplantation (HCT) for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) between patients receiving myeloablative conditioning (NAC) versus reduced intensity conditioning (RIC) regimens.

Study Number: 

NCG 218612

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01339910

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.